Gene Symbol | Gene ID | Gene Info |
---|---|---|
TBP
|
ENSG00000112592.8 | TATA-box binding protein |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_170864148_170864457 | TBP | 609 | 0.698705 | 0.85 | 3.8e-03 | Click! |
chr6_170863869_170864115 | TBP | 299 | 0.874527 | 0.69 | 3.8e-02 | Click! |
chr6_170865271_170865422 | TBP | 1653 | 0.362994 | 0.62 | 7.6e-02 | Click! |
chr6_170864471_170864804 | TBP | 944 | 0.541880 | 0.54 | 1.4e-01 | Click! |
chr6_170865874_170866044 | TBP | 2266 | 0.295740 | 0.06 | 8.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_144508892_144509461 | 2.09 |
TPK1 |
thiamin pyrophosphokinase 1 |
23970 |
0.23 |
chr11_65869163_65869474 | 2.03 |
PACS1 |
phosphofurin acidic cluster sorting protein 1 |
1084 |
0.36 |
chr3_32413676_32413926 | 1.96 |
CMTM7 |
CKLF-like MARVEL transmembrane domain containing 7 |
19362 |
0.23 |
chr1_111210638_111210814 | 1.87 |
KCNA3 |
potassium voltage-gated channel, shaker-related subfamily, member 3 |
6929 |
0.19 |
chr10_127476698_127477090 | 1.84 |
MMP21 |
matrix metallopeptidase 21 |
12504 |
0.12 |
chr9_4639969_4640120 | 1.67 |
PPAPDC2 |
phosphatidic acid phosphatase type 2 domain containing 2 |
22254 |
0.16 |
chr4_40249519_40249765 | 1.62 |
RHOH |
ras homolog family member H |
47678 |
0.14 |
chr8_129405598_129405852 | 1.62 |
ENSG00000201782 |
. |
172975 |
0.03 |
chrX_103367091_103367582 | 1.59 |
ZCCHC18 |
zinc finger, CCHC domain containing 18 |
10134 |
0.18 |
chr20_16714291_16714442 | 1.57 |
RP4-705D16.3 |
|
2773 |
0.25 |
chr6_130832933_130833235 | 1.56 |
ENSG00000202438 |
. |
62173 |
0.12 |
chr8_61440352_61440503 | 1.54 |
RAB2A |
RAB2A, member RAS oncogene family |
10687 |
0.22 |
chr9_20740624_20740775 | 1.51 |
ENSG00000207609 |
. |
24595 |
0.17 |
chr19_47689628_47689845 | 1.49 |
ENSG00000265134 |
. |
40463 |
0.1 |
chr12_9177186_9177502 | 1.48 |
RP11-259O18.4 |
|
28182 |
0.13 |
chr17_1776866_1777017 | 1.47 |
RPA1 |
replication protein A1, 70kDa |
5388 |
0.17 |
chr10_22030567_22030830 | 1.47 |
ENSG00000252634 |
. |
43523 |
0.16 |
chr5_66512764_66513039 | 1.47 |
CD180 |
CD180 molecule |
20274 |
0.26 |
chr13_59966448_59966793 | 1.47 |
ENSG00000239003 |
. |
87584 |
0.11 |
chr11_45396634_45396934 | 1.46 |
SYT13 |
synaptotagmin XIII |
88914 |
0.09 |
chr14_64964646_64964818 | 1.42 |
ZBTB1 |
zinc finger and BTB domain containing 1 |
5711 |
0.13 |
chr5_40623336_40623578 | 1.41 |
ENSG00000199552 |
. |
31608 |
0.19 |
chr14_101105925_101106191 | 1.41 |
CTD-2644I21.1 |
|
50395 |
0.08 |
chr2_106478506_106478657 | 1.40 |
AC009505.2 |
|
4948 |
0.27 |
chr18_67615445_67615629 | 1.40 |
CD226 |
CD226 molecule |
448 |
0.89 |
chr6_24954931_24955192 | 1.40 |
FAM65B |
family with sequence similarity 65, member B |
18873 |
0.21 |
chr9_123665604_123665920 | 1.40 |
TRAF1 |
TNF receptor-associated factor 1 |
11088 |
0.19 |
chr3_18444556_18444707 | 1.39 |
RP11-158G18.1 |
|
6496 |
0.24 |
chr20_49543758_49543983 | 1.37 |
ADNP |
activity-dependent neuroprotector homeobox |
1483 |
0.3 |
chr5_55989860_55990011 | 1.36 |
AC022431.2 |
Homo sapiens uncharacterized LOC101928448 (LOC101928448), mRNA. |
87876 |
0.08 |
chr22_40302237_40302507 | 1.36 |
GRAP2 |
GRB2-related adaptor protein 2 |
5259 |
0.19 |
chr13_95160153_95160347 | 1.35 |
DCT |
dopachrome tautomerase |
28314 |
0.19 |
chr6_16475281_16475432 | 1.35 |
ENSG00000265642 |
. |
46602 |
0.19 |
chr12_9909080_9909231 | 1.35 |
CD69 |
CD69 molecule |
4342 |
0.18 |
chr17_8340253_8340508 | 1.35 |
NDEL1 |
nudE neurodevelopment protein 1-like 1 |
968 |
0.46 |
chr8_81289205_81289813 | 1.34 |
ENSG00000252884 |
. |
28242 |
0.19 |
chr1_101416000_101416317 | 1.34 |
SLC30A7 |
solute carrier family 30 (zinc transporter), member 7 |
11226 |
0.16 |
chr17_20178582_20178828 | 1.34 |
ENSG00000252971 |
. |
14865 |
0.17 |
chr4_123142185_123142336 | 1.33 |
KIAA1109 |
KIAA1109 |
1636 |
0.52 |
chr1_121292288_121292467 | 1.33 |
FCGR1B |
Fc fragment of IgG, high affinity Ib, receptor (CD64) |
356440 |
0.01 |
chr1_101394347_101394839 | 1.32 |
SLC30A7 |
solute carrier family 30 (zinc transporter), member 7 |
32783 |
0.12 |
chr15_66113317_66113516 | 1.32 |
ENSG00000252715 |
. |
22406 |
0.15 |
chr7_130785566_130785775 | 1.32 |
LINC-PINT |
long intergenic non-protein coding RNA, p53 induced transcript |
6119 |
0.22 |
chr1_154128026_154128318 | 1.32 |
NUP210L |
nucleoporin 210kDa-like |
580 |
0.61 |
chr9_130823428_130823579 | 1.32 |
RP11-379C10.1 |
|
3862 |
0.12 |
chr3_3213817_3214181 | 1.31 |
CRBN |
cereblon |
7359 |
0.19 |
chr18_21612789_21612982 | 1.31 |
TTC39C |
tetratricopeptide repeat domain 39C |
16287 |
0.16 |
chr7_7191102_7191397 | 1.30 |
C1GALT1 |
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 |
5316 |
0.2 |
chr7_86840512_86840739 | 1.30 |
ENSG00000200397 |
. |
7403 |
0.18 |
chr3_109524271_109524422 | 1.30 |
ENSG00000265956 |
. |
202671 |
0.03 |
chr15_60855427_60855584 | 1.29 |
RORA |
RAR-related orphan receptor A |
29235 |
0.16 |
chr2_144049594_144049745 | 1.29 |
RP11-190J23.1 |
|
119928 |
0.06 |
chr19_41795344_41795495 | 1.29 |
ENSG00000239868 |
. |
2820 |
0.16 |
chr7_148609620_148609917 | 1.29 |
ENSG00000239468 |
. |
22462 |
0.13 |
chr2_114451770_114451921 | 1.28 |
ENSG00000202427 |
. |
13157 |
0.17 |
chr5_56145222_56145512 | 1.27 |
ENSG00000238717 |
. |
7608 |
0.16 |
chr5_150522953_150523279 | 1.27 |
ANXA6 |
annexin A6 |
1900 |
0.36 |
chr3_16880178_16880359 | 1.27 |
PLCL2 |
phospholipase C-like 2 |
46184 |
0.18 |
chr1_111760357_111760508 | 1.27 |
CHI3L2 |
chitinase 3-like 2 |
9206 |
0.13 |
chr5_169703034_169703822 | 1.26 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
9097 |
0.23 |
chr11_60874245_60874396 | 1.24 |
CD5 |
CD5 molecule |
4339 |
0.21 |
chr7_50350560_50351095 | 1.22 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
2509 |
0.41 |
chr5_56030322_56030651 | 1.22 |
MAP3K1 |
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
80915 |
0.08 |
chr14_61852684_61852835 | 1.22 |
PRKCH |
protein kinase C, eta |
4653 |
0.28 |
chr11_60214353_60214504 | 1.22 |
MS4A1 |
membrane-spanning 4-domains, subfamily A, member 1 |
8797 |
0.16 |
chr1_160635836_160636303 | 1.21 |
RP11-404F10.2 |
|
4499 |
0.18 |
chr13_74341711_74341984 | 1.21 |
KLF12 |
Kruppel-like factor 12 |
227339 |
0.02 |
chr6_489632_490047 | 1.21 |
RP1-20B11.2 |
|
34332 |
0.22 |
chr14_98485289_98485572 | 1.21 |
C14orf64 |
chromosome 14 open reading frame 64 |
40969 |
0.22 |
chr2_175353345_175353496 | 1.21 |
GPR155 |
G protein-coupled receptor 155 |
1598 |
0.4 |
chr14_98910958_98911243 | 1.19 |
ENSG00000241757 |
. |
93099 |
0.09 |
chr9_132656652_132657013 | 1.19 |
FNBP1 |
formin binding protein 1 |
24757 |
0.14 |
chr1_161746977_161747182 | 1.19 |
ATF6 |
activating transcription factor 6 |
10995 |
0.13 |
chr1_198578902_198579207 | 1.18 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
28747 |
0.21 |
chr17_3615168_3615388 | 1.18 |
CTD-3195I5.3 |
|
9644 |
0.1 |
chr13_74520897_74521048 | 1.18 |
KLF12 |
Kruppel-like factor 12 |
48214 |
0.2 |
chr14_68754417_68754568 | 1.17 |
ENSG00000243546 |
. |
51236 |
0.16 |
chr9_97347238_97347389 | 1.17 |
FBP2 |
fructose-1,6-bisphosphatase 2 |
8762 |
0.24 |
chr6_74155389_74155663 | 1.17 |
MB21D1 |
Mab-21 domain containing 1 |
6456 |
0.1 |
chr14_23033091_23033244 | 1.17 |
AE000662.93 |
|
7211 |
0.11 |
chr21_16002379_16002642 | 1.17 |
AF165138.7 |
Protein LOC388813 |
12944 |
0.23 |
chr2_12850945_12851096 | 1.17 |
TRIB2 |
tribbles pseudokinase 2 |
5995 |
0.28 |
chr6_106505003_106505293 | 1.17 |
PRDM1 |
PR domain containing 1, with ZNF domain |
29047 |
0.2 |
chr1_206746783_206747082 | 1.17 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
16439 |
0.15 |
chr14_90105259_90105410 | 1.17 |
RP11-944C7.1 |
Protein LOC100506792 |
7424 |
0.15 |
chr4_109448642_109448957 | 1.17 |
ENSG00000266046 |
. |
49497 |
0.16 |
chr16_29758241_29758468 | 1.16 |
C16orf54 |
chromosome 16 open reading frame 54 |
1027 |
0.3 |
chr7_127698825_127699005 | 1.16 |
ENSG00000207588 |
. |
22998 |
0.2 |
chr5_66512559_66512710 | 1.16 |
CD180 |
CD180 molecule |
20007 |
0.26 |
chr2_143896794_143897048 | 1.15 |
ARHGAP15 |
Rho GTPase activating protein 15 |
10038 |
0.25 |
chr14_23013063_23013415 | 1.15 |
AE000662.92 |
Uncharacterized protein |
12295 |
0.1 |
chr5_40624066_40624286 | 1.15 |
ENSG00000199552 |
. |
30889 |
0.19 |
chr7_17177840_17177991 | 1.15 |
AC003075.4 |
|
143012 |
0.05 |
chr5_172461890_172462041 | 1.15 |
ENSG00000212402 |
. |
14234 |
0.14 |
chr21_19148494_19148866 | 1.14 |
AL109761.5 |
|
17125 |
0.22 |
chr1_91387563_91387714 | 1.14 |
ZNF644 |
zinc finger protein 644 |
99376 |
0.09 |
chr22_40798855_40799170 | 1.14 |
SGSM3 |
small G protein signaling modulator 3 |
5305 |
0.17 |
chr17_47837882_47838168 | 1.14 |
FAM117A |
family with sequence similarity 117, member A |
3468 |
0.2 |
chr6_166902327_166902583 | 1.14 |
ENSG00000222958 |
. |
20466 |
0.16 |
chr11_72866229_72866512 | 1.14 |
FCHSD2 |
FCH and double SH3 domains 2 |
13064 |
0.2 |
chr14_103946613_103946810 | 1.14 |
MARK3 |
MAP/microtubule affinity-regulating kinase 3 |
5250 |
0.14 |
chr8_66713941_66714092 | 1.14 |
PDE7A |
phosphodiesterase 7A |
12697 |
0.26 |
chr18_13613063_13613400 | 1.13 |
LDLRAD4 |
low density lipoprotein receptor class A domain containing 4 |
613 |
0.61 |
chr6_99962458_99962681 | 1.13 |
USP45 |
ubiquitin specific peptidase 45 |
683 |
0.66 |
chrX_128919724_128919915 | 1.13 |
SASH3 |
SAM and SH3 domain containing 3 |
5859 |
0.21 |
chr16_11059004_11059432 | 1.12 |
CLEC16A |
C-type lectin domain family 16, member A |
20780 |
0.13 |
chr20_45181715_45181866 | 1.12 |
OCSTAMP |
osteoclast stimulatory transmembrane protein |
2577 |
0.3 |
chr3_195252483_195252634 | 1.12 |
ENSG00000252620 |
. |
2539 |
0.24 |
chr15_72771584_72771735 | 1.11 |
ARIH1 |
ariadne RBR E3 ubiquitin protein ligase 1 |
4673 |
0.24 |
chr10_23657373_23657637 | 1.11 |
C10orf67 |
chromosome 10 open reading frame 67 |
23731 |
0.14 |
chrX_149884862_149885013 | 1.11 |
MTMR1 |
myotubularin related protein 1 |
2212 |
0.42 |
chr8_79455569_79455720 | 1.11 |
PKIA |
protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
27054 |
0.22 |
chr6_112311435_112311966 | 1.11 |
WISP3 |
WNT1 inducible signaling pathway protein 3 |
63575 |
0.11 |
chr17_8801323_8801785 | 1.11 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
13270 |
0.21 |
chr5_14706237_14706388 | 1.10 |
FAM105B |
family with sequence similarity 105, member B |
24653 |
0.19 |
chr7_37381820_37382186 | 1.10 |
ELMO1 |
engulfment and cell motility 1 |
364 |
0.89 |
chr15_52016567_52016776 | 1.10 |
RP11-313P18.1 |
|
9254 |
0.14 |
chr14_61809956_61810279 | 1.10 |
PRKCH |
protein kinase C, eta |
843 |
0.65 |
chr12_92427299_92427519 | 1.10 |
C12orf79 |
chromosome 12 open reading frame 79 |
103388 |
0.07 |
chr15_86188672_86188945 | 1.10 |
AKAP13 |
A kinase (PRKA) anchor protein 13 |
342 |
0.83 |
chr6_167454306_167454826 | 1.10 |
FGFR1OP |
FGFR1 oncogene partner |
41670 |
0.11 |
chr4_24557660_24557830 | 1.10 |
ENSG00000243005 |
. |
7339 |
0.22 |
chr6_167455887_167456163 | 1.09 |
FGFR1OP |
FGFR1 oncogene partner |
43129 |
0.11 |
chr17_47825399_47825554 | 1.09 |
FAM117A |
family with sequence similarity 117, member A |
16017 |
0.14 |
chr11_67962188_67962401 | 1.09 |
SUV420H1 |
suppressor of variegation 4-20 homolog 1 (Drosophila) |
17927 |
0.18 |
chr12_9915185_9915438 | 1.09 |
CD69 |
CD69 molecule |
1814 |
0.3 |
chr3_15001032_15001235 | 1.09 |
NR2C2 |
nuclear receptor subfamily 2, group C, member 2 |
2781 |
0.29 |
chr12_69066031_69066182 | 1.09 |
NUP107 |
nucleoporin 107kDa |
14408 |
0.19 |
chr11_13947171_13947350 | 1.09 |
ENSG00000201856 |
. |
18123 |
0.28 |
chr20_35222813_35222964 | 1.09 |
RP5-977B1.11 |
|
10044 |
0.12 |
chr6_167534795_167535192 | 1.09 |
CCR6 |
chemokine (C-C motif) receptor 6 |
1264 |
0.46 |
chr12_72054493_72054659 | 1.09 |
THAP2 |
THAP domain containing, apoptosis associated protein 2 |
2213 |
0.24 |
chr10_11189501_11189652 | 1.09 |
CELF2 |
CUGBP, Elav-like family member 2 |
17417 |
0.19 |
chr7_37479339_37479814 | 1.09 |
ENSG00000201566 |
. |
4858 |
0.21 |
chr18_13562704_13562990 | 1.09 |
RP11-53B2.4 |
|
2187 |
0.22 |
chr18_47313047_47313239 | 1.09 |
ACAA2 |
acetyl-CoA acyltransferase 2 |
24758 |
0.13 |
chr13_75870489_75870925 | 1.08 |
TBC1D4 |
TBC1 domain family, member 4 |
44960 |
0.17 |
chr16_79313702_79313853 | 1.08 |
ENSG00000222244 |
. |
15426 |
0.29 |
chr5_49713436_49713587 | 1.08 |
EMB |
embigin |
11050 |
0.32 |
chr13_41225309_41225460 | 1.08 |
FOXO1 |
forkhead box O1 |
15350 |
0.23 |
chr15_70848608_70848759 | 1.08 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
145937 |
0.05 |
chr7_150218642_150218920 | 1.08 |
GIMAP7 |
GTPase, IMAP family member 7 |
6863 |
0.2 |
chr14_23035018_23035185 | 1.08 |
AE000662.93 |
|
9145 |
0.11 |
chr17_37926788_37926952 | 1.08 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
7608 |
0.14 |
chr1_29309816_29309967 | 1.07 |
ENSG00000206704 |
. |
2331 |
0.34 |
chr17_66250172_66250736 | 1.07 |
AMZ2 |
archaelysin family metallopeptidase 2 |
4126 |
0.18 |
chr2_175473426_175473849 | 1.07 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
10698 |
0.19 |
chr12_4257445_4257654 | 1.07 |
CCND2 |
cyclin D2 |
125389 |
0.05 |
chr2_8444424_8444575 | 1.07 |
AC011747.7 |
|
371397 |
0.01 |
chr5_156616881_156617104 | 1.07 |
ITK |
IL2-inducible T-cell kinase |
9155 |
0.13 |
chr3_194119463_194119614 | 1.06 |
GP5 |
glycoprotein V (platelet) |
455 |
0.8 |
chr2_190457094_190457308 | 1.06 |
SLC40A1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
8717 |
0.23 |
chr3_68106398_68106747 | 1.06 |
FAM19A1 |
family with sequence similarity 19 (chemokine (C-C motif)-like), member A1 |
51199 |
0.19 |
chr1_159037154_159037495 | 1.06 |
ENSG00000265589 |
. |
8285 |
0.18 |
chr4_77914541_77914885 | 1.06 |
SEPT11 |
septin 11 |
2322 |
0.37 |
chr13_99955364_99955631 | 1.06 |
GPR183 |
G protein-coupled receptor 183 |
4162 |
0.24 |
chr17_64197432_64197583 | 1.06 |
CEP112 |
centrosomal protein 112kDa |
9310 |
0.22 |
chr14_89688879_89689030 | 1.05 |
FOXN3 |
forkhead box N3 |
41866 |
0.19 |
chr2_197014969_197015443 | 1.05 |
RP11-347P5.1 |
|
781 |
0.66 |
chr7_38406025_38406176 | 1.05 |
AMPH |
amphiphysin |
96613 |
0.09 |
chr2_172255817_172255968 | 1.05 |
METTL8 |
methyltransferase like 8 |
34608 |
0.18 |
chr11_6716702_6716921 | 1.05 |
MRPL17 |
mitochondrial ribosomal protein L17 |
12179 |
0.11 |
chr20_21534809_21534960 | 1.05 |
NKX2-2 |
NK2 homeobox 2 |
40220 |
0.16 |
chr8_66860684_66860968 | 1.05 |
DNAJC5B |
DnaJ (Hsp40) homolog, subfamily C, member 5 beta |
72969 |
0.11 |
chr1_114885611_114885814 | 1.04 |
TRIM33 |
tripartite motif containing 33 |
120146 |
0.06 |
chr17_33755333_33755563 | 1.04 |
SLFN12 |
schlafen family member 12 |
4095 |
0.17 |
chr5_14983835_14984240 | 1.04 |
ENSG00000212036 |
. |
73288 |
0.11 |
chr1_160511238_160511428 | 1.04 |
ENSG00000264286 |
. |
4202 |
0.15 |
chr8_19283724_19284349 | 1.04 |
SH2D4A |
SH2 domain containing 4A |
106935 |
0.08 |
chr18_3253501_3253674 | 1.04 |
MYL12A |
myosin, light chain 12A, regulatory, non-sarcomeric |
1314 |
0.38 |
chr16_53471043_53471490 | 1.04 |
RBL2 |
retinoblastoma-like 2 (p130) |
1735 |
0.31 |
chr1_150065281_150065432 | 1.04 |
VPS45 |
vacuolar protein sorting 45 homolog (S. cerevisiae) |
25471 |
0.14 |
chr18_13381370_13381535 | 1.03 |
LDLRAD4 |
low density lipoprotein receptor class A domain containing 4 |
1101 |
0.46 |
chr2_42526156_42526376 | 1.03 |
EML4 |
echinoderm microtubule associated protein like 4 |
2127 |
0.4 |
chr9_117141639_117141997 | 1.03 |
AKNA |
AT-hook transcription factor |
1903 |
0.36 |
chrX_78431490_78431736 | 1.03 |
GPR174 |
G protein-coupled receptor 174 |
5144 |
0.35 |
chr1_172787968_172788219 | 1.03 |
FASLG |
Fas ligand (TNF superfamily, member 6) |
159935 |
0.04 |
chr5_49659605_49659756 | 1.03 |
EMB |
embigin |
64881 |
0.15 |
chr6_150038264_150038454 | 1.03 |
LATS1 |
large tumor suppressor kinase 1 |
811 |
0.56 |
chr5_130626437_130626711 | 1.03 |
CDC42SE2 |
CDC42 small effector 2 |
26781 |
0.25 |
chr14_50558007_50558396 | 1.02 |
C14orf183 |
chromosome 14 open reading frame 183 |
1160 |
0.41 |
chr19_16478620_16478771 | 1.02 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
5931 |
0.16 |
chrX_153390327_153390718 | 1.02 |
OPN1LW |
opsin 1 (cone pigments), long-wave-sensitive |
19176 |
0.12 |
chr2_224822884_224823038 | 1.02 |
MRPL44 |
mitochondrial ribosomal protein L44 |
840 |
0.61 |
chrX_135755622_135755773 | 1.02 |
CD40LG |
CD40 ligand |
25311 |
0.16 |
chr17_46375004_46375203 | 1.02 |
AC090627.1 |
|
3366 |
0.23 |
chr7_97742885_97743050 | 1.02 |
LMTK2 |
lemur tyrosine kinase 2 |
6770 |
0.24 |
chr6_90663606_90663820 | 1.02 |
RP3-512E2.2 |
|
3583 |
0.22 |
chr1_66832278_66832866 | 1.02 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
12507 |
0.29 |
chr6_33828198_33828349 | 1.02 |
MLN |
motilin |
56485 |
0.11 |
chr18_60957499_60957729 | 1.01 |
RP11-28F1.2 |
|
23701 |
0.16 |
chr15_93507111_93507262 | 1.01 |
CHD2 |
chromodomain helicase DNA binding protein 2 |
7927 |
0.25 |
chrX_134428617_134428815 | 1.01 |
ZNF75D |
zinc finger protein 75D |
1243 |
0.52 |
chr15_60838437_60838624 | 1.01 |
CTD-2501E16.2 |
|
16358 |
0.18 |
chr11_128591338_128591530 | 1.01 |
SENCR |
smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA |
25516 |
0.16 |
chr21_34577882_34578369 | 1.01 |
IFNAR2 |
interferon (alpha, beta and omega) receptor 2 |
24081 |
0.13 |
chr7_150252736_150253017 | 1.01 |
GIMAP4 |
GTPase, IMAP family member 4 |
11489 |
0.19 |
chr15_63774655_63774806 | 1.00 |
USP3 |
ubiquitin specific peptidase 3 |
22063 |
0.21 |
chr2_198145756_198145978 | 1.00 |
ANKRD44-IT1 |
ANKRD44 intronic transcript 1 (non-protein coding) |
21376 |
0.16 |
chr2_235187354_235187505 | 1.00 |
ARL4C |
ADP-ribosylation factor-like 4C |
217815 |
0.02 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 1.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.0 | 2.9 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.9 | 2.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.8 | 2.5 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.8 | 3.3 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.7 | 2.9 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.7 | 0.7 | GO:0002664 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.7 | 5.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.6 | 2.6 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.6 | 1.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.6 | 2.6 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.6 | 1.7 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.6 | 1.7 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.6 | 0.6 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.6 | 2.9 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.5 | 2.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 4.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 1.6 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.5 | 4.1 | GO:0002834 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.5 | 1.0 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.5 | 0.5 | GO:0002507 | tolerance induction(GO:0002507) |
0.5 | 1.5 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.5 | 1.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.5 | 1.5 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.5 | 0.5 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.5 | 1.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.5 | 1.4 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.5 | 1.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 2.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 1.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.4 | 0.8 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.4 | 1.9 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.4 | 1.6 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.4 | 0.8 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.4 | 3.5 | GO:0043368 | positive T cell selection(GO:0043368) |
0.4 | 1.5 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 0.7 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.4 | 2.6 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.4 | 1.1 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.4 | 1.1 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
0.4 | 1.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 0.7 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 1.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.4 | 0.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.4 | 1.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.4 | 0.4 | GO:0002833 | positive regulation of response to biotic stimulus(GO:0002833) |
0.4 | 0.4 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.3 | 2.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 1.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 0.7 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.3 | 3.0 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 1.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 1.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 0.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.3 | 0.6 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.3 | 0.3 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.3 | 0.3 | GO:0017085 | response to insecticide(GO:0017085) |
0.3 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 0.6 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 0.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 0.6 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.3 | 1.5 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.3 | 0.9 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.3 | 0.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 0.9 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 1.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 0.6 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.3 | 0.9 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.3 | 0.8 | GO:0060596 | mammary placode formation(GO:0060596) |
0.3 | 0.3 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.3 | 1.1 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.3 | 3.0 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.3 | 0.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 1.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 1.9 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.3 | 0.8 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.3 | 0.8 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 0.8 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 0.5 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.3 | 1.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 0.8 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.3 | 0.5 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.3 | 0.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 1.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.3 | 6.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.3 | 1.0 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.3 | 0.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 1.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 1.0 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.2 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.5 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.2 | 0.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.2 | 1.5 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.2 | 0.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 1.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 0.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.7 | GO:0010447 | response to acidic pH(GO:0010447) |
0.2 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 1.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.7 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.2 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.3 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.2 | 0.4 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.2 | 0.4 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.2 | 1.3 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.2 | 1.7 | GO:0000090 | mitotic anaphase(GO:0000090) |
0.2 | 0.2 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.2 | 0.4 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.2 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 1.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 13.0 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.2 | 0.4 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.2 | 0.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 2.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.6 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.2 | 1.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 0.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.2 | 1.8 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 0.8 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 2.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 1.0 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.2 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.2 | 1.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 0.4 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.2 | 0.8 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.2 | 0.2 | GO:0071027 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 0.6 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 0.4 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.2 | 0.2 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.2 | 0.7 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 0.4 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.2 | 0.5 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.2 | 0.2 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.2 | 1.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 0.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.2 | 0.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 3.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.2 | 0.9 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.2 | 0.5 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.2 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 1.0 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.2 | 0.3 | GO:0033079 | immature T cell proliferation(GO:0033079) |
0.2 | 0.5 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.2 | 0.9 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 0.2 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) transcription factor import into nucleus(GO:0042991) |
0.2 | 0.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.3 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.7 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 1.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 0.7 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.5 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 0.5 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 0.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.7 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.2 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.2 | 0.8 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.2 | 0.8 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 0.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 2.6 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.2 | 4.1 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 0.5 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.2 | 2.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 0.7 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.7 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.2 | 0.7 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.2 | 0.6 | GO:0001840 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
0.2 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 1.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.5 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.2 | 0.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 0.3 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.2 | 0.8 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.5 | GO:0021853 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.2 | 0.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.5 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.2 | 0.6 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.2 | 0.8 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.2 | 1.8 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 0.5 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.1 | 0.6 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.1 | 0.7 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.3 | GO:0070602 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.1 | 2.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.4 | GO:0009188 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.4 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.1 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.1 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 1.7 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.7 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 1.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.1 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.7 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.7 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.4 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.3 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.3 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.6 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 3.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.8 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.7 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.4 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.6 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.4 | GO:0090196 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.1 | 0.5 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 1.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.8 | GO:0030260 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.1 | 0.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.5 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 1.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.4 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.1 | 0.5 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.4 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 0.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.1 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.4 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 1.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.3 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 1.0 | GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching(GO:0060678) |
0.1 | 0.4 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.1 | 0.3 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.1 | 1.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.4 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.5 | GO:1901160 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.1 | 0.4 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 1.0 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.6 | GO:0072273 | metanephric nephron morphogenesis(GO:0072273) |
0.1 | 0.2 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 0.1 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) |
0.1 | 0.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.8 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.1 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.5 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.5 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 1.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.5 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.2 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.5 | GO:1902305 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.7 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.3 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 1.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.1 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 0.1 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) sodium ion export(GO:0071436) |
0.1 | 1.3 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.9 | GO:0006379 | mRNA cleavage(GO:0006379) RNA phosphodiester bond hydrolysis(GO:0090501) |
0.1 | 0.1 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.1 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.2 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.2 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.1 | 0.3 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.1 | 0.8 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 1.5 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 0.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.1 | 0.2 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.2 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 2.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.2 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.1 | 0.3 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.2 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.1 | 0.4 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.5 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 2.0 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.2 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.1 | 0.2 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.1 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.6 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.4 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 1.3 | GO:0042308 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
0.1 | 0.3 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.4 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 1.1 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 0.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.5 | GO:0042098 | T cell proliferation(GO:0042098) |
0.1 | 0.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 0.2 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.1 | 0.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.3 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.4 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 1.3 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 1.5 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 | 0.2 | GO:0051208 | sequestering of calcium ion(GO:0051208) |
0.1 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.5 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.4 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.2 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.3 | GO:0042435 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) indole-containing compound biosynthetic process(GO:0042435) |
0.1 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.5 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.3 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.1 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 1.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 1.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.4 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.1 | 0.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.1 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.1 | GO:2000351 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 1.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 4.8 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 1.7 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.3 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.9 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.5 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.1 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 0.5 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 4.7 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.2 | GO:0070265 | necrotic cell death(GO:0070265) |
0.1 | 4.8 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.1 | 0.2 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.1 | 0.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.3 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 0.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.3 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.1 | GO:0032353 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.1 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.1 | 0.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.1 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.1 | 0.7 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 0.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.2 | GO:0035269 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.1 | 1.2 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.1 | 0.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.2 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 0.3 | GO:0021707 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 1.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.1 | 0.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.2 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.2 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.5 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.3 | GO:0015853 | adenine transport(GO:0015853) |
0.1 | 0.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 1.6 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.2 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 2.0 | GO:1903037 | regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
0.1 | 0.2 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.1 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.1 | 0.3 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 0.9 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.4 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.2 | GO:0003207 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.1 | 0.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.4 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.2 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.2 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.1 | 0.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.5 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.4 | GO:0042891 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.1 | 0.1 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.1 | 0.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.1 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.7 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.4 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.1 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 1.4 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.1 | 5.5 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.1 | GO:0010042 | response to manganese ion(GO:0010042) |
0.1 | 0.1 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.3 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.3 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 10.0 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 0.2 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.1 | 0.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.1 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 0.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.1 | 0.1 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 2.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.1 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.1 | 0.2 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 0.3 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.3 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.5 | GO:0001662 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.1 | 0.5 | GO:0046386 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) deoxyribose phosphate catabolic process(GO:0046386) |
0.1 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.7 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 3.9 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.7 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.1 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.1 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.1 | 1.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.3 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 0.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 2.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.2 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.1 | 1.1 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 1.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.4 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 0.4 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.5 | GO:0010458 | exit from mitosis(GO:0010458) |
0.1 | 2.9 | GO:0072401 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 0.1 | GO:0051647 | nucleus localization(GO:0051647) |
0.1 | 0.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.3 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.1 | 0.8 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.2 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.9 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 1.1 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.1 | 0.6 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 2.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.5 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.1 | 0.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.2 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 0.8 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.8 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.1 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 2.3 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 1.5 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 0.1 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.8 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.1 | 0.2 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.1 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.1 | 0.1 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 0.6 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.1 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 6.5 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 1.0 | GO:0021549 | cerebellum development(GO:0021549) |
0.1 | 0.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 1.5 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.1 | GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) |
0.1 | 1.4 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.1 | GO:0043331 | response to dsRNA(GO:0043331) |
0.1 | 0.8 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.4 | GO:0001825 | blastocyst formation(GO:0001825) |
0.1 | 0.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.2 | GO:0008595 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.1 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 0.1 | GO:0042267 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 0.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.2 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.4 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.5 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.1 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.1 | 0.6 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.1 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 1.5 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.1 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.1 | 0.3 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.1 | GO:0015851 | nucleobase transport(GO:0015851) |
0.1 | 0.1 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.2 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 1.1 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.1 | 0.1 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.1 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.2 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.1 | 0.1 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.1 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.6 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.7 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.0 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 1.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.1 | GO:0016444 | somatic diversification of immune receptors via germline recombination within a single locus(GO:0002562) somatic cell DNA recombination(GO:0016444) somatic recombination of immunoglobulin gene segments(GO:0016447) |
0.0 | 1.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.3 | GO:0031396 | regulation of protein ubiquitination(GO:0031396) |
0.0 | 0.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.0 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.9 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 1.8 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.9 | GO:0016571 | histone methylation(GO:0016571) |
0.0 | 0.2 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.0 | 0.0 | GO:0019935 | cGMP-mediated signaling(GO:0019934) cyclic-nucleotide-mediated signaling(GO:0019935) |
0.0 | 0.0 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) labyrinthine layer morphogenesis(GO:0060713) |
0.0 | 0.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:0000097 | sulfur amino acid biosynthetic process(GO:0000097) |
0.0 | 0.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.0 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.0 | 0.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.3 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.0 | 0.1 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.0 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.1 | GO:0002449 | lymphocyte mediated immunity(GO:0002449) |
0.0 | 0.6 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 13.0 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.1 | GO:0016236 | macroautophagy(GO:0016236) |
0.0 | 0.3 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.0 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
0.0 | 0.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.0 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.9 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.0 | 0.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 1.4 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.0 | 0.3 | GO:0006323 | DNA packaging(GO:0006323) |
0.0 | 1.3 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.0 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.3 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.1 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.0 | 0.0 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 1.0 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.0 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.0 | 0.5 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.0 | 0.1 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.0 | GO:0021533 | cell differentiation in hindbrain(GO:0021533) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.4 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 2.7 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.4 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.0 | 0.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.0 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.0 | 0.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.3 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.0 | 0.2 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.0 | 0.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.7 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.0 | 0.1 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.2 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.0 | 0.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 3.9 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.0 | 0.3 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.0 | 0.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.0 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.4 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
0.0 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.0 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.5 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.2 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 1.3 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 5.7 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 | 0.2 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.0 | 0.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.5 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 2.8 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.3 | GO:0016045 | detection of bacterium(GO:0016045) |
0.0 | 0.1 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.5 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.0 | GO:0071503 | response to heparin(GO:0071503) |
0.0 | 0.7 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.0 | 0.0 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.1 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.6 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.0 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 0.1 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.0 | 0.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.1 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.1 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.0 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.2 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.0 | 0.0 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.0 | 0.1 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.2 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:1901989 | positive regulation of cell cycle phase transition(GO:1901989) positive regulation of mitotic cell cycle phase transition(GO:1901992) |
0.0 | 0.1 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.0 | 0.0 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.0 | GO:0002002 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.0 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.0 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.2 | GO:0001510 | RNA methylation(GO:0001510) |
0.0 | 0.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.4 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.0 | 0.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.3 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.2 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 1.3 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.5 | GO:0044782 | cilium organization(GO:0044782) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.1 | GO:0043900 | regulation of multi-organism process(GO:0043900) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.5 | GO:0051591 | response to cAMP(GO:0051591) |
0.0 | 0.4 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.1 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.9 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.0 | GO:0016458 | gene silencing(GO:0016458) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.0 | 0.1 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.1 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0030147 | obsolete natriuresis(GO:0030147) |
0.0 | 0.0 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.0 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.0 | 0.0 | GO:0034121 | regulation of toll-like receptor signaling pathway(GO:0034121) |
0.0 | 0.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.0 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.0 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) |
0.0 | 0.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.1 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.0 | 0.0 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.0 | 0.1 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.1 | GO:0033133 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 2.1 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 1.2 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.0 | 0.2 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 0.0 | GO:0055067 | monovalent inorganic cation homeostasis(GO:0055067) |
0.0 | 0.0 | GO:0072599 | protein targeting to ER(GO:0045047) protein localization to endoplasmic reticulum(GO:0070972) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.0 | 0.2 | GO:0046131 | pyrimidine ribonucleoside metabolic process(GO:0046131) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 | 0.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.0 | GO:0042117 | monocyte activation(GO:0042117) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.0 | 0.2 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.0 | 0.1 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.0 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.0 | 0.0 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.0 | 0.3 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.0 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.0 | 3.8 | GO:0007599 | hemostasis(GO:0007599) |
0.0 | 0.1 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.0 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.0 | 2.7 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 0.0 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.1 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.2 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.1 | GO:0045980 | negative regulation of nucleotide metabolic process(GO:0045980) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.0 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.0 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.6 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.0 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.4 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.0 | 0.0 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.2 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.0 | GO:0050777 | negative regulation of immune response(GO:0050777) |
0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.0 | 0.0 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 0.0 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.0 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.0 | GO:0021532 | neural tube patterning(GO:0021532) |
0.0 | 0.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.0 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.1 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.0 | 0.0 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 0.0 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.7 | 5.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 1.7 | GO:0072487 | MSL complex(GO:0072487) |
0.5 | 1.8 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 5.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 0.4 | GO:0005694 | chromosome(GO:0005694) |
0.4 | 5.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 1.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 1.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 3.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 1.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.3 | 2.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 1.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 1.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 1.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 1.5 | GO:0000791 | euchromatin(GO:0000791) |
0.3 | 2.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 1.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 0.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 2.5 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.4 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.2 | 0.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 2.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 0.6 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.8 | GO:0016604 | nuclear body(GO:0016604) |
0.2 | 6.8 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.6 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 1.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 1.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 0.7 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 0.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 1.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 0.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 1.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 3.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 2.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 1.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 1.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.4 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.1 | 2.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 4.1 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 0.5 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 1.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 1.6 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 2.1 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.7 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 1.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.7 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.5 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.1 | 1.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.2 | GO:0031312 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of organelle membrane(GO:0031312) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 3.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.8 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.6 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 1.2 | GO:0005844 | polysome(GO:0005844) |
0.1 | 1.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.6 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.1 | 0.4 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 10.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 2.6 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.1 | 0.4 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.1 | 0.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.1 | 2.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 1.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.2 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.4 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 1.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.8 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.1 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.3 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 3.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.8 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 4.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 8.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 1.9 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 1.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 2.7 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 1.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.5 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 2.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.7 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.8 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.7 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.1 | 3.0 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 1.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.9 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 2.6 | GO:0016605 | PML body(GO:0016605) |
0.1 | 6.7 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 2.6 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 0.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.6 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 1.9 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 1.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.1 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 4.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 1.0 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 2.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 1.1 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.6 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.3 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.1 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.0 | 38.9 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.0 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 1.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 1.1 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 4.4 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.2 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 2.6 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.2 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 2.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 12.8 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.6 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 2.3 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.0 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.3 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.9 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 15.4 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 2.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.7 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 98.5 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0044304 | main axon(GO:0044304) |
0.0 | 0.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.0 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.2 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.7 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 1.6 | GO:0019867 | outer membrane(GO:0019867) |
0.0 | 0.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.2 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.0 | 0.3 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 4.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 1.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 3.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.0 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 2.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.9 | GO:0070013 | intracellular organelle lumen(GO:0070013) |
0.0 | 0.0 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 0.3 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 1.2 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.0 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 2.1 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.2 | GO:0005773 | vacuole(GO:0005773) |
0.0 | 53.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.0 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.0 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.0 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.5 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.9 | 2.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 3.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.6 | 8.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 2.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.5 | 3.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 1.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 4.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 1.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.4 | 1.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 1.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 1.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.4 | 1.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 3.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 2.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 1.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 1.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 2.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 3.1 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.3 | 1.0 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.3 | 1.0 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 1.0 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.3 | 1.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 4.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 0.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 0.9 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 0.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 1.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 1.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 0.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 0.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.3 | 3.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 1.4 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 0.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 0.5 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.3 | 3.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 1.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 2.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 1.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.3 | 1.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 1.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.3 | 1.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 1.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 1.0 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 1.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 2.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 1.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.7 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.2 | 1.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.7 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 0.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.2 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 4.8 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 4.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 1.2 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 3.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 2.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 1.0 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.2 | 0.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 1.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.4 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 0.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.6 | GO:0005048 | signal sequence binding(GO:0005048) |
0.2 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 5.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 1.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 1.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 1.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.5 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 1.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 1.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 1.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 1.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 2.4 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 3.2 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 0.5 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 1.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 0.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 2.4 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.2 | 1.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 0.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 1.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.2 | 0.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.8 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.5 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 0.6 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 0.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 1.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 3.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 3.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 2.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 6.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.8 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.5 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.5 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 1.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 1.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 2.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 1.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 0.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 3.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.6 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.1 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.7 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 5.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.4 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.1 | 0.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 6.7 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 0.1 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.3 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 1.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 1.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 2.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.3 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.3 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.1 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 1.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.5 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.3 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.1 | 1.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 3.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.5 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 1.2 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.4 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.6 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.6 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.7 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.4 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 0.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.3 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.1 | 1.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.5 | GO:0004396 | hexokinase activity(GO:0004396) |
0.1 | 1.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 3.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 2.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.4 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.3 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 2.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 2.6 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.7 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 1.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 3.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 7.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 2.7 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.1 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 2.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 1.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 1.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.4 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.5 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 0.3 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.2 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.3 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.4 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.7 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 1.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 1.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 2.4 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.2 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.1 | 0.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 1.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.8 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 1.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 2.4 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.5 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.7 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 1.4 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.6 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.8 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 1.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.3 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 2.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.2 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.1 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.1 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.7 | GO:0005035 | death receptor activity(GO:0005035) |
0.1 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.5 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.1 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.1 | 0.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 6.4 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 1.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.2 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 2.9 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 24.9 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.1 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.1 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.2 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.1 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.3 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.1 | 1.1 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.4 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 8.5 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 1.2 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.0 | GO:0000036 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.0 | 0.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 0.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.0 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 1.3 | GO:0044389 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 1.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.2 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.2 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 4.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 2.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.5 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 1.2 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.2 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.1 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.3 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.0 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.0 | 2.2 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 1.6 | GO:0008134 | transcription factor binding(GO:0008134) |
0.0 | 63.4 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.7 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.7 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.0 | 0.2 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 7.7 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.0 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.2 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.1 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.0 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 1.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.6 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.5 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 0.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 5.1 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.0 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.4 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 1.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.0 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.2 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.1 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.0 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.0 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.0 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.3 | GO:0015297 | antiporter activity(GO:0015297) |
0.0 | 0.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.0 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 25.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.4 | 9.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 5.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 3.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 4.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 10.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 5.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 9.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 2.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 8.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 0.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 9.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 2.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 5.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 5.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 1.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 1.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 2.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 2.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 3.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 3.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 2.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 2.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 3.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 2.0 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 3.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 3.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 3.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 3.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 2.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 2.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 1.9 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.6 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 1.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.6 | 1.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.5 | 7.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 1.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 7.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 9.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 9.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 1.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 7.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 2.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 5.7 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.3 | 2.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 2.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 5.0 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.3 | 5.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 0.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 7.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 5.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 2.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 3.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 4.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 9.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 3.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 1.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 1.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 3.4 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.2 | 4.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 5.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 2.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 1.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.8 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 1.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 2.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 2.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 3.2 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 1.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 4.7 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 1.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 1.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 5.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 4.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 2.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 0.8 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.2 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 0.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.3 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 0.9 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 0.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 3.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 4.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 2.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 2.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 2.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.1 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.1 | 1.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.7 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 7.9 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 2.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 7.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 3.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.6 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 2.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 1.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.5 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 1.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.7 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 1.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 1.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.4 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 1.0 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.3 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 1.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 4.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.4 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.1 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 1.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |